Rasche L - Search Results

1

Obinutuzumab and venetoclax induced complete remission in a patient with ibrutinib-resistant non-nodal leukemic mantle cell lymphoma.

Zhou X, Steinhardt MJ, Düll J, Krummenast F, Danhof S, Meckel K, Nickel K, Grathwohl D, Leicht HB, Rosenwald A, Einsele H, Rasche L, Kortüm M. Zhou X, et al. Among authors: rasche l. Eur J Haematol. 2020 Apr;104(4):352-355. doi: 10.1111/ejh.13382. Epub 2020 Jan 21. Eur J Haematol. 2020. PMID: 31922303

2

Cellular therapy to control tumor progression.

Kapp M, Rasche L, Einsele H, Grigoleit GU. Kapp M, et al. Among authors: rasche l. Curr Opin Hematol. 2009 Nov;16(6):437-43. doi: 10.1097/MOH.0b013e32832f57d4. Curr Opin Hematol. 2009. PMID: 19587587 Review.

3

Features of extramedullary myeloma relapse: high proliferation, minimal marrow involvement, adverse cytogenetics: a retrospective single-center study of 24 cases.

Rasche L, Bernard C, Topp MS, Kapp M, Duell J, Wesemeier C, Haralambieva E, Maeder U, Einsele H, Knop S. Rasche L, et al. Ann Hematol. 2012 Jul;91(7):1031-7. doi: 10.1007/s00277-012-1414-5. Ann Hematol. 2012. PMID: 22286070

4

The natural human IgM antibody PAT-SM6 induces apoptosis in primary human multiple myeloma cells by targeting heat shock protein GRP78.

Rasche L, Duell J, Morgner C, Chatterjee M, Hensel F, Rosenwald A, Einsele H, Topp MS, Brändlein S. Rasche L, et al. PLoS One. 2013 May 7;8(5):e63414. doi: 10.1371/journal.pone.0063414. Print 2013. PLoS One. 2013. PMID: 23667612 Free PMC article.

5

EBV-induced post transplant lymphoproliferative disorders: a persisting challenge in allogeneic hematopoetic SCT.

Rasche L, Kapp M, Einsele H, Mielke S. Rasche L, et al. Bone Marrow Transplant. 2014 Feb;49(2):163-7. doi: 10.1038/bmt.2013.96. Epub 2013 Jul 8. Bone Marrow Transplant. 2014. PMID: 23832092 Review.

6

The lymphoma-like polychemotherapy regimen "Dexa-BEAM" in advanced and extramedullary multiple myeloma.

Rasche L, Strifler S, Duell J, Rosenwald A, Buck A, Maeder U, Einsele H, Knop S. Rasche L, et al. Ann Hematol. 2014 Jul;93(7):1207-14. doi: 10.1007/s00277-014-2023-2. Epub 2014 Feb 14. Ann Hematol. 2014. PMID: 24526137

7

Primary bone marrow diffuse large B-cell lymphoma affecting distal parts of the legs as a cause of persisting B symptoms.

Lapa C, Knott M, Rasche L, Herrmann K, Buck AK, Rosenwald A. Lapa C, et al. Among authors: rasche l. Eur J Haematol. 2014 Dec;93(6):545-6. doi: 10.1111/ejh.12305. Epub 2014 Mar 26. Eur J Haematol. 2014. PMID: 24612353 No abstract available.

8

GRP78-directed immunotherapy in relapsed or refractory multiple myeloma - results from a phase 1 trial with the monoclonal immunoglobulin M antibody PAT-SM6.

Rasche L, Duell J, Castro IC, Dubljevic V, Chatterjee M, Knop S, Hensel F, Rosenwald A, Einsele H, Topp MS, Brändlein S. Rasche L, et al. Haematologica. 2015 Mar;100(3):377-84. doi: 10.3324/haematol.2014.117945. Epub 2015 Jan 30. Haematologica. 2015. PMID: 25637055 Free PMC article. Clinical Trial.

9

Immunotherapy for viral and fungal infections.

Einsele H, Löffler J, Kapp M, Rasche L, Mielke S, Grigoleit UG. Einsele H, et al. Among authors: rasche l. Bone Marrow Transplant. 2015 Jun;50 Suppl 2:S51-4. doi: 10.1038/bmt.2015.96. Bone Marrow Transplant. 2015. PMID: 26039208 Review.

10

'Real-life' experience of preapproval carfilzomib-based therapy in myeloma - analysis of cardiac toxicity and predisposing factors.

Danhof S, Schreder M, Rasche L, Strifler S, Einsele H, Knop S. Danhof S, et al. Among authors: rasche l. Eur J Haematol. 2016 Jul;97(1):25-32. doi: 10.1111/ejh.12677. Epub 2015 Sep 21. Eur J Haematol. 2016. PMID: 26331915

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

151 results

Search Page